Protherics PLC, the biopharmaceutical company focused on critical care and oncology (the "Company"), received notification on 20 January 2006 from Legal & General Investment Management Limited that Legal & General Group PLC and/or its subsidiaries ("Legal & General") no longer has a notifiable interest in the share capital of the Company.
